Clinical Trials Browser

Neuroectodermal Tumors, Primitive, Pyloric Stenosis, Hypertrophic

Lung Neoplasms, Small Cell Lung Carcinoma

Diffuse Intrinsic Pontine Glioma, Glioma, Medulloblastoma

Gastrointestinal Stromal Tumors

Glioblastoma, Gliosarcoma

Glioblastoma, Gliosarcoma

Glioblastoma

Neuroblastoma

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

Colorectal Adenocarcinoma

Adenoma, Islet Cell

Glioblastoma

Colorectal Neoplasms, Microsatellite Instability

Recurrence, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma

Ependymoma, Medulloblastoma, Recurrence

Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

Neuroblastoma

Glioblastoma

Glioblastoma

Brain Neoplasms, Marijuana Abuse, Glioblastoma, Recurrence

Primary Glioblastoma

Glioblastoma

Astrocytoma, Glioblastoma, Oligodendroglioma

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Ependymoma, Glioblastoma, Medulloblastoma

Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

Neuroblastoma

Leiomyosarcoma, Sarcoma

Glioblastoma

Brain Neoplasms, Glioblastoma

Glioblastoma

Glioblastoma

Lung Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors, Small Cell Lung Carcinoma

Triple Negative Breast Neoplasms

Glioblastoma

Neuroendocrine Tumors

Glioblastoma

Glioblastoma

Glioblastoma, Glioma, Gliosarcoma

Glioblastoma

Small Cell Lung Carcinoma

Glioblastoma, Glioma

Fallopian Tube Neoplasms, Ovarian Neoplasms

Glioblastoma, Meningeal Carcinomatosis

Glioblastoma

Glioblastoma

Rhabdomyosarcoma

Clinical Trials

PNOC031

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

GIST

SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma

Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer

Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas

Liposomal Irinotecan in Combination With Temozolomide and Bevacizumab in Patients With Advanced STS

Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

Surgical Pembro +/- Olaparib w TMZ for rGBM

ARETHUSA

Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid Tumors

MEMMAT

Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors

N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

2-THE-TOP

Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study

ARISTOCRAT

MATVAC-1

Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Phase II Study of Chidamide-Dinutuximab Beta-Irinotecan-Temozolomide for Refractory/Relapsed Neuroblastoma in Children

Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma

Newly Diagnosed Glioblastoma

Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma

Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma

VIGAS2

Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme

Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer

Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC)

A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme

CapTemY90

OPTIMUM

hSTAR GBM

Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma

INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)

TRIO-US L-07

NeoGlio

Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer

18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy

Stupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced Spread

G-CSF After Chemo-radiation in Patients With Glioblastoma

Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma

Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease